138 related articles for article (PubMed ID: 17853164)
1. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.
Parashar P; Iversen OE; Midbøe G; Myking O; Bjørge L
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):366-71. PubMed ID: 17853164
[TBL] [Abstract][Full Text] [Related]
2. Mifepristone and misoprostol for early abortion when no gestational sac is present.
Schaff EA; Fielding SL; Eisinger S; Stadalius L
Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
[TBL] [Abstract][Full Text] [Related]
3. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
[TBL] [Abstract][Full Text] [Related]
4. Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin.
Chou SY; Chen CY; Chiang HK; Chow PK; Wang CC; Hsu CS
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):48-52. PubMed ID: 17272208
[TBL] [Abstract][Full Text] [Related]
5. Concurrent use of mifepristone and misoprostol for early medical abortion.
Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
[TBL] [Abstract][Full Text] [Related]
6. Medical abortion at 63 to 90 days of gestation.
Løkeland M; Iversen OE; Dahle GS; Nappen MH; Ertzeid L; Bjørge L
Obstet Gynecol; 2010 May; 115(5):962-968. PubMed ID: 20410769
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
Li YT; Hsieh JC; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Tang HH; Kuo TC
Taiwan J Obstet Gynecol; 2011 Mar; 50(1):11-4. PubMed ID: 21482367
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
9. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
[TBL] [Abstract][Full Text] [Related]
11. Use of mifepristone and sublingual misoprostol for early medical abortion.
Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
[TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
Dahiya K; Mann S; Nanda S
Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
[TBL] [Abstract][Full Text] [Related]
14. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
[TBL] [Abstract][Full Text] [Related]
15. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
Murthy AS; Creinin MD; Harwood B; Schreiber C
Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
[TBL] [Abstract][Full Text] [Related]
17. Early pregnancy termination with mifepristone and misoprostol in Norway.
Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
[TBL] [Abstract][Full Text] [Related]
18. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
[TBL] [Abstract][Full Text] [Related]
19. Serum hCG threshold to assess medical abortion success.
Le Lous M; Gallinand AC; Laviolle B; Peltier L; Nyangoh Timoh K; Lavoué V
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):458-463. PubMed ID: 30601107
[TBL] [Abstract][Full Text] [Related]
20. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.
Fiala C; Safar P; Bygdeman M; Gemzell-Danielsson K
Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):190-5. PubMed ID: 12860340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
